USD 6.9 billion
Cell Therapy Market Size, Share, and Growth Analysis
Cell Therapy Market By Technology (Somatic Cell Technology, Cell Immortalization Technology), By Type (Autologous, Allogeneic), By Cell Type (Stem Cell, Non-Stem Cell), By Cell Source (iPSCs, Bone Marrow), By Application (Musculoskeletal, Cardiovascular), By End-User, By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35H2061 |
Region:
Global |
Published Date: July, 2024
Pages:
157
|Tables:
132
|Figures:
77
Format -
Cell Therapy Market Insights
Global Cell Therapy Market size was valued at USD 6.9 billion in 2023 and is poised to grow from USD 8.38 billion in 2024 to USD 39.81 billion by 2032, growing at a CAGR of 21.5% during the forecast period (2025-2032).
Rising incidence of degenerative disorders and chronic diseases is projected to be the primary driver behind cell therapy market growth. Growing use of cell therapies to treat various diseases and high investments in cell research are also expected to create new opportunities for market players in the future. Advancements in stem cell research and growing demand for regenerative medicine are also expected to foster new business scope for cell therapy providers going forward. High demand for personalized medicine is also estimated to uplift the demand for cell therapies across the forecast period and beyond. On the contrary, high costs of development, risk of rejection, and complex regulatory approval procedures are estimated to be key restraints for cell therapy market over the coming years.
US Cell Therapy Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
academic and research institutions
Fastest Growth
Hospitals and clinics
Growth Rate
21.5% CAGR
Global Cell Therapy Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Cell Therapy Market Segments Analysis
Global Cell Therapy Market is segmented by Technology, Type, Cell Type, Cell Source, Application, End-User and region. Based on Technology, the market is segmented into Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology and Three-Dimensional Technology. Based on Type, the market is segmented into Autologous and Allogeneic. Based on Cell Type, the market is segmented into Stem Cell and Non-Stem Cell. Based on Cell Source, the market is segmented into iPSCs, Bone Marrow, Umbilical Cord Blood-Derived Cells, Adipose Tissues and Neural Stem Cell. Based on Application, the market is segmented into Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Wounds and Injuries, Ocular and Others. Based on End-User, the market is segmented into Hospitals and Clinics, Regenerative Medicine Centres, Diagnostic and Research Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Analysis by Cell Type
Stem cells are projected to account for a major chunk of the global cell therapy market share. The ability of stem cells to be programmed to perform biological function makes them a preferred choice for all types of cell therapies. Growing demand for regenerative medicine around the world is forecasted to help this segment maintain its dominance in the future. Advancements in stem cell research are also expected to favor market growth going forward.
Meanwhile, the demand for non-stem cells is estimated to increase at a rapid pace in the long run. Advancements in personalized medicine and growing awareness regarding alternative therapies around the world are also expected to help this segment bring in more revenue in the long run. Increasing approvals of new therapies are also expected to help this segment promote market growth through 2031.
Analysis by End User
Use of cell therapy in academic and research institutions is estimated to account for a dominant share of the global market. Growing investments in medical research and rising use of cell therapies by researchers are also expected to contribute to the high market share of this segment going forward. Supportive government initiatives and funding are also expected to create new business scope via this segment in the future.
Hospitals and clinics are projected to emerge as the fastest-growing end user of cell therapies in the future. Rising regulatory approvals of cell therapies for the treatment of several chronic diseases are projected to help this segment boost market growth going forward. Cell therapies are also being used for diagnosis and this is also expected to contribute to the rapid growth of this segment.
Global Cell Therapy Market By End User
To get detailed analysis on other segments, Request For Free Sample Report
Cell Therapy Market Regional Insights
North America is projected to account for a dominant share of the global cell therapy market in the future. High investments in medical R&D, the presence of key biotechnology companies, and supportive government funding are key factors that are estimated to help the high market share of this region. Canada and the United States are slated to be the top markets for cell therapy companies in this region. High demand for cell therapies to treat chronic diseases will also favor market growth in this region.
Asia Pacific is expected to emerge as the fastest-expanding market for cell therapies in the world going forward. Growing awareness regarding benefits of cell therapies, high investments in healthcare infrastructure development, and rising acceptance of cell therapies are top factors that will create new opportunities for cell therapy companies in the future. Japan, China, and India are slated to be the key markets in this region.
Global Cell Therapy Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Cell Therapy Market Dynamics
Cell Therapy Market Driver
Demand for Personalized Medicine
- Rapidly increasing demand for personalized medicine around the world is boosting the adoption of novel cell therapies as they are crucial in targeting specific characteristics of an individual. Cell therapies also help in identifying the efficacy of therapy on an individual to reduce the risk of rejection.
Advancements in Stem Cell Research
- Reseach on stem cells has come a long way and most cell therapies are building on the knowledge obtained through stem cell research. These advancements are further opening new scope for innovation for cell therapy companies.
Restraints
Immune Rejection Risk
- There is always a risk of immune rejection for cell therapies, and this is an issue that is influentially impeding market growth potential. This is a particular threat for allogeneic cell therapies thereby slowing cell therapy adoption.
High Costs of Development
- Extensive amount of research and resources required for cell therapy research and development lead to high costs. Cell therapy treatments are also quite expensive due to their novel nature and these high costs inhibit cell therapy market growth.
Request Free Customization of this report to help us to meet your business objectives.
Cell Therapy Market Competitive Landscape
Cell therapy companies can also benefit from government grants and supportive initiatives launched to help boost medical R&D. Cell therapy providers should invest heavily in research to boost innovation and stand out from the competition. New companies can penetrate the market with hefty capital raise and innovative approach to compete with established market players. Integration of advanced technologies to fast-track development will also be a key strategy for cell therapy companies in the future.
Cell Therapy Market Top Players' Company Profiles
- Novartis AG (Switzerland)
- Gilead Sciences, Inc. (USA)
- Bristol Myers Squibb (USA)
- Johnson & Johnson (USA)
- Takeda Pharmaceutical Company Limited (Japan)
- Bluebird Bio, Inc. (USA)
- Mesoblast Limited (Australia)
- CRISPR Therapeutics (Switzerland)
- Adaptimmune Therapeutics plc (UK)
- Fate Therapeutics, Inc. (USA)
- Orchard Therapeutics plc (UK)
- Gamida Cell Ltd. (Israel)
- Allogene Therapeutics, Inc. (USA)
- Capricor Therapeutics, Inc. (USA)
- Vericel Corporation (USA)
- Mustang Bio, Inc. (USA)
- Atara Biotherapeutics, Inc. (USA)
Cell Therapy Market Recent Developments
- This year in January 2024, Kite Pharma received approval for a new CAR-T manufacturing process that will help speed up the turnaround times for Yescarta-related therapies. This approval will help shorten manufacturing time by 2 days, making it 5 days from the previous 7 days.
- Back again in January 2024, Fate Therapeutics announced the start of its new Phase I clinical trial in collaboration with Ono Pharmaceutical of solid tumour therapy. Chimeric antigen receptor (CAR) T-cell therapy is being used to treat solid tumours and this trial assesses its safety and tolerability among patients.
Cell Therapy Key Market Trends
CAR-T Cell Therapy:
- The prevalence of cancer has increased exponentially on a global level and so has the need for novel treatments as well. CAR-T (Chimeric Antigen Receptor T-cell) therapy is emerging as a popular immunotherapy for the treatment of various cancers, companies can capitalize on this trend to maximize their business scope in the long run.
Cell Therapy Market SkyQuest Analysis
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, high investments in medical R&D, advancements in stem cell research, and supportive government initiatives are slated to bolster the global demand for cell therapies going forward. However, high costs of development and treatment coupled with immune rejection risks are slated to impede cell therapy adoption in the future. North America is slated to be the top market in the world owing to high investments in medical R&D and the presence of a developed healthcare infrastructure. Developing cell therapies for cancer treatment will pay off big time for all cell therapy companies in the long run.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 6.9 billion |
| Market size value in 2032 | USD 39.81 billion |
| Growth Rate | 21.5% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Cell Therapy Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Cell Therapy Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Cell Therapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cell Therapy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cell Therapy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Cell Therapy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
